Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 42

1.

Crystal structure of human macrophage elastase (MMP-12) in complex with a hydroxamic acid inhibitor.

Nar H, Werle K, Bauer MM, Dollinger H, Jung B.

J Mol Biol. 2001 Sep 28;312(4):743-51.

PMID:
11575929
2.

Matrix metalloproteinase inhibitors: a review on pharmacophore mapping and (Q)SARs results.

Kontogiorgis CA, Papaioannou P, Hadjipavlou-Litina DJ.

Curr Med Chem. 2005;12(3):339-55. Review.

PMID:
15723623
3.

Matrix metalloproteases: variations on a theme.

Borkakoti N.

Prog Biophys Mol Biol. 1998;70(1):73-94. Review.

PMID:
9785958
4.

Role of sulfonamide group in matrix metalloproteinase inhibitors.

Cheng XC, Wang Q, Fang H, Xu WF.

Curr Med Chem. 2008;15(4):368-73. Review.

PMID:
18288991
5.

Insights into MMP-TIMP interactions.

Bode W, Fernandez-Catalan C, Grams F, Gomis-Rüth FX, Nagase H, Tschesche H, Maskos K.

Ann N Y Acad Sci. 1999 Jun 30;878:73-91. Review.

PMID:
10415721
6.

Future challenges facing the development of specific active-site-directed synthetic inhibitors of MMPs.

Cuniasse P, Devel L, Makaritis A, Beau F, Georgiadis D, Matziari M, Yiotakis A, Dive V.

Biochimie. 2005 Mar-Apr;87(3-4):393-402. Review.

PMID:
15781327
7.

Engineering of selective TIMPs.

Nagase H, Meng Q, Malinovskii V, Huang W, Chung L, Bode W, Maskos K, Brew K.

Ann N Y Acad Sci. 1999 Jun 30;878:1-11. Review.

PMID:
10415716
8.

[A turning point in the knowledge of the structure-function-activity relations of elastin].

Alix AJ.

J Soc Biol. 2001;195(2):181-93. Review. French.

PMID:
11727705
9.

Crystal structures of MMPs in complex with physiological and pharmacological inhibitors.

Maskos K.

Biochimie. 2005 Mar-Apr;87(3-4):249-63. Review.

PMID:
15781312
11.

Matrix metalloprotease inhibitors: design from structure.

Borkakoti N.

Biochem Soc Trans. 2004 Feb;32(Pt 1):17-20. Review.

PMID:
14748704
12.

[Metalloproteinases in the extracellular matrix: structure and activity].

Cuvelier A, Kuntz C, Sesboüé R, Muir JF, Martin JP.

Rev Mal Respir. 1997 Jan;14(1):1-10. Review. French.

PMID:
9082500
13.

Third generation of matrix metalloprotease inhibitors: Gain in selectivity by targeting the depth of the S1' cavity.

Devel L, Czarny B, Beau F, Georgiadis D, Stura E, Dive V.

Biochimie. 2010 Nov;92(11):1501-8. doi: 10.1016/j.biochi.2010.07.017. Epub 2010 Aug 7. Review.

PMID:
20696203
14.

Specificity of binding with matrix metalloproteinases.

Gupta SP, Patil VM.

EXS. 2012;103:35-56. doi: 10.1007/978-3-0348-0364-9_2. Review.

PMID:
22642189
15.

Selectivity, binding affinity, and ionization state of matrix metalloproteinase inhibitors.

Zhong HA, Arbiser J, Bowen JP.

Curr Pharm Des. 2013;19(26):4701-13. Review.

PMID:
23260023
16.

Structural studies of the role of the active site metal in metalloenzymes.

Feinberg H, Greenblatt HM, Shoham G.

J Chem Inf Comput Sci. 1993 May-Jun;33(3):501-16. Review.

PMID:
8320293
17.
18.

Recent advances in studies on hydroxamates as matrix metalloproteinase inhibitors: a review.

Yadav RK, Gupta SP, Sharma PK, Patil VM.

Curr Med Chem. 2011;18(11):1704-22. Review.

PMID:
21428880
19.

Functional and structural insights into astacin metallopeptidases.

Gomis-Rüth FX, Trillo-Muyo S, Stöcker W.

Biol Chem. 2012 Oct;393(10):1027-41. doi: 10.1515/hsz-2012-0149. Review.

PMID:
23092796
20.

Structural features of a superfamily of zinc-endopeptidases: the metzincins.

Stöcker W, Bode W.

Curr Opin Struct Biol. 1995 Jun;5(3):383-90. Review.

PMID:
7583637

Supplemental Content

Support Center